Coronavirus Update: US Adds To Antibody Push With $486m AstraZeneca Deal
Plus: Bharat To Start Phase III Vaccine Trials Shortly
• By Scrip Team
AstraZeneca's COVID-19 vaccine trial is still halted in the US, but the company is forging ahead with a new antibody therapy deal with the government. 
